Ceapro Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Ceapro Fair Value Forecast for 2023 - 2025 - 2030
Ceapro's Price has decreased In the last two years, from C$0.30 to C$0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach C$0.00 – an increase of 100.00%. For the next six years, experts predict that Ceapro's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WEED Stock Forecast | Canopy Growth | Hold |
7
|
C$15.76 | Buy/Sell | C$0.94 | -61.93% |
| INNO Stock Forecast | InnoCan Pharma | - |
6
|
C$0.27 | Buy/Sell | C$0.00 | -100.00% |
| NGW Stock Forecast | Next Green Wave Holdings | - |
0
|
C$0.39 | Buy/Sell | C$0.00 | -100.00% |
| ACST Stock Forecast | Acasti Pharma | Buy |
0
|
$2.85 | Buy/Sell | $16.34 | 182.81% |
| FLOO.F Stock Forecast | Flower One Holdings | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Ceapro Revenue Forecast for 2023 - 2025 - 2030
Ceapro's Revenue has grown In the last two years, rising from C$15.12M to C$18.84M – a growth of 24.60%. In the following year, 0 experts forecast Ceapro's Revenue will decrease by 9.83%, to C$16.99M. In 2030, professionals predict that Ceapro's Revenue will decrease by 9.31%, to C$17.09M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XTRX Stock Forecast | Adastra Holdings | - |
0
|
C$0.20 | Buy/Sell | C$0.00 | -100.00% |
| CNFA Stock Forecast | CanaFarma Hemp Products | - |
0
|
C$0.05 | Buy/Sell | C$0.00 | -100.00% |
| CANQ.F Stock Forecast | CanaQuest Medical | - |
0
|
$0.14 | Buy/Sell | $0.98 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NLV Stock Forecast | New Leaf Ventures Inc | - |
0
|
C$0.04 | Buy/Sell | C$0.00 | -100.00% |
| MOJO Stock Forecast | Mojave Brands | - |
4
|
C$0.32 | Buy/Sell | C$0.00 | -100.00% |
| IPOT Stock Forecast | Isracann Biosciences | - |
3
|
C$0.02 | Buy/Sell | C$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CFT Stock Forecast | Craftport Cannabis | - |
0
|
C$0.05 | Buy/Sell | C$0.00 | -100.00% |
| FUEL Stock Forecast | PlantFuel Life | - |
-16
|
C$0.01 | Buy/Sell | C$0.00 | -100.00% |
| CRFT Stock Forecast | BC Craft Supply | - |
0
|
C$0.50 | Buy/Sell | C$0.00 | -100.00% |
Ceapro EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Ceapro's EBITDA has grown, moving from C$3.72M to C$6.38M – an increase of 71.51%. According to 0 analysts, Ceapro's EBITDA will fall by 27.23% in the next year, reaching C$4.64M. Professionals believe that By 2030, Ceapro's EBITDA will fall to C$4.90M – a 23.26% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| J Stock Forecast | Lotus Ventures | - |
10
|
C$0.01 | Buy/Sell | C$0.00 | -100.00% |
| CANA Stock Forecast | CannAmerica Brands | - |
0
|
C$0.02 | Buy/Sell | C$0.00 | -100.00% |
| NHP Stock Forecast | Lumiera Health | - |
4
|
C$0.01 | Buy/Sell | C$0.00 | -100.00% |
Ceapro EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Ceapro's EBIT has seen an increase, rising from C$2.35M to C$5.50M. This represents a growth of 134.04%. In the following year, 0 experts forecast that Ceapro's EBIT will decrease by 38.34%, to C$3.39M. In 2030, professionals predict that Ceapro's EBIT will decrease by 30.05%, to C$3.85M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SE Stock Forecast | Sweet Earth Holdings | - |
-18
|
C$0.05 | Buy/Sell | C$0.00 | -100.00% |
| CBD.U Stock Forecast | Hempfusion Wellness | - |
0
|
$0.00 | Buy/Sell | $0.39 | 0.00% |
| GDBY.F Stock Forecast | Goodbody Health | - |
-17
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Ceapro EPS Price Prediction Forecast for 2023 - 2025 - 2030
Ceapro's EPS has decreased In the last two years, from C$0.02 to C$0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach C$0.00 – an increase of 100.00%. For the next six years, experts predict that Ceapro's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSD Stock Forecast | Devonian Health Group | - |
0
|
0.15 | Buy/Sell | 0.00 | -100.00% |
| CCAN Stock Forecast | Canadian Cannabis | - |
0
|
0.00 | Buy/Sell | 0.00 | 0.00% |
| BLRS Stock Forecast | BioLife Remedies | - |
0
|
0.00 | Buy/Sell | 0.00 | 0.00% |
.jpg)